C. Goodwin

发表

Helicobacter pylori gastritis, peptic ulcer, and gastric cancer: clinical and molecular aspects.

C. Goodwin, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Control of methicillin-resistant Staphylococcus aureus (MRSA) in an Australian metropolitan teaching hospital complex.

C. Goodwin, C. Metcalf, K. Christiansen, 1985, The Medical journal of Australia.

DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORI

B. Marshall, J. Warren, C. Goodwin, 1989, The Lancet.

Rapid urease test in the management of Campylobacter pyloridis-associated gastritis.

B. Marshall, J. Warren, C. Goodwin, 1987, The American journal of gastroenterology.

DUODENAL ULCER, CAMPYLOBACTER PYLORI, AND THE "LEAKING ROOF" CONCEPT

C. Goodwin, 1988, The Lancet.

Unusual cellular fatty acids and distinctive ultrastructure in a new spiral bacterium (Campylobacter pyloridis) from the human gastric mucosa.

J. Armstrong, C. Goodwin, R. Mcculloch, 1985, Journal of medical microbiology.

Campylobacter mustelae, a New Species Resulting from the Elevation of Campylobacter pylori subsp. mustelae to Species Status

D. J. Brenner, C. Goodwin, P. Edmonds, 1989 .

Intracellular vacuolization caused by the urease of Helicobacter pylori.

C. Goodwin, M. Cooper, J. K. Xu, 1990, The Journal of infectious diseases.

Soluble and cell-associated haemagglutinins of Helicobacter (Campylobacter) pylori.

B. Mee, C. Goodwin, M. Cooper, 1990, Journal of medical microbiology.

Cellular fatty acid composition of Campylobacter pylori from primates and ferrets compared with those of other campylobacters

C. Goodwin, M. Bronsdon, R. Mcculloch, 1989, Journal of clinical microbiology.

The Sydney System: Microbial gastritis

C. Goodwin, 1991, Journal of gastroenterology and hepatology.

Original isolation of Campylobacter pyloridis from human gastric mucosa

B. Marshall, J. Warren, J. Armstrong, 1984 .

Helicobacter pylori (Campylobacter pylori) and duodenal ulcer

C. Goodwin, V. Burke, A. Gordon, 1990, The Medical journal of Australia.

Helicobacter pylori infection

T. Northfield, C. Goodwin, Michael M Mendall, 1997, The Lancet.

Taxonomy of Helicobacter pylori and Related Bacteria

C. Goodwin, 1990 .

Sol u b le a n d ce I I - associated h aern agg I u t i n i ns of Helicobacter (Camp ylobacter) p ylori

C. Goodwin, V. Burke, B. MEEt, 1990 .

Helicobacter ( Camp ylobacter ) p ylori

C. Goodwin, V. Burke, B. MEEt, 2022 .

Antimicrobial treatment of Helicobacter pylori infection.

C. Goodwin, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORI

B. Marshall, C. Goodwin, BarryJ. Marshall, 1988, The Lancet.

Antimicrobial and phytochemical screening of medicinal plants of the United Arab Emirates.

C. Goodwin, M. Tanira, N. Banna, 1994, Journal of ethnopharmacology.

Microbes and infections of the gut.

C. S. Goodwin, C. Goodwin, 1984 .

Microbiological aspects ofHelicobacter pylori (Campylobacter pylori)

J. Armstrong, C. Goodwin, 2005, European Journal of Clinical Microbiology and Infectious Diseases.

Campylobacter pyloridis, gastritis, and peptic ulceration.

B. Marshall, J. Armstrong, C. Goodwin, 1986, Journal of clinical pathology.

The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis.

C. Goodwin, E. Blincow, P. Blake, 1986, The Journal of antimicrobial chemotherapy.

Lysis of Enterobacteria by Cefoxitin, Cefuroxime, and Cephalothin

C. Goodwin, J. Hill, 1977, Antimicrobial Agents and Chemotherapy.

Detection of bacteriuria in women attending local authority antenatal clinics using the dip-inoculum transport medium spoon method

C. Goodwin, A. E. Stewart, 1968, Journal of clinical pathology.

Will antibacterial chemotherapy be efficacious for gastritis and peptic ulcer?

J. Armstrong, C. Goodwin, 1986, The Journal of antimicrobial chemotherapy.

Computer printing and filing of microbiology reports. 1. Description of the system.

C. Goodwin, B. C. Smith, 1976, Journal of clinical pathology.

The use of in-vitro sensitivity testing to predict clinical response of recurrent herpes simplex to suppressive oral acyclovir.

D. Smith, C. Goodwin, 1988, The Journal of antimicrobial chemotherapy.

Effects of Rate of Infusion and Probenecid on Serum Levels, Renal Excretion, and Tolerance of Intravenous Doses of Cefoxitin in Humans: Comparison with Cephalothin

E. Raftery, C. M. Martin, A. Goldberg, 1974, Antimicrobial Agents and Chemotherapy.

Comparison of Techniques for the Isolation of T-strain Mycoplasmas

D. Taylor-Robinson, C. Goodwin, J. P. Addey, 1969, Nature.

RECURRENT URINARY INFECTIONS, ANALYSED BY GEL CHROMATOGRAPHY

C. Goodwin, J. Green, L. Webb, 2007 .

Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.

B. Marshall, C. Goodwin, D. Wilson, 1988, Journal of clinical pathology.

Peptic ulcer disease and Helicobacter pylori infection

C. Goodwin, J. Carrick, 1991 .

Antibiotics in Helicobacter pylori Treatment

C. Goodwin, 1994 .

Evaluation of cultural techniques for isolating Campylobacter pyloridis from endoscopic biopsies of gastric mucosa.

J. Warren, C. Goodwin, T. E. Waters, 1985, Journal of clinical pathology.

Enzyme-linked immunosorbent assay for Campylobacter pyloridis: correlation with presence of C. pyloridis in the gastric mucosa.

B. Marshall, J. Warren, C. Goodwin, 1987, The Journal of infectious diseases.

THE ASSOCIATION OF BACTERIURIA AND REDUCED SERUM PYRIDOXAL CONCENTRATIONS IN PATIENTS WITH DIABETES MELLITUS

R. Davis, C. Goodwin, V. McCann, 1981, Pathology.

Gastric cancer and Helicobacter pylori

P. I. Reed, C. Goodwin, M. Hill, 1993, The Lancet.

Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov. as Helicobacter pylori comb. nov. and Helicobacter mustelae comb. nov., Respectively

M. Collins, J. Armstrong, C. Goodwin, 1989 .

Response of Campylobacter pyloridis to antibiotics, bismuth and an acid-reducing agent in vitro--an ultrastructural study.

J. Armstrong, C. Goodwin, D. Wilson, 1987, Journal of medical microbiology.

The use of the voluntary muscle test in leprosy neuritis.

C. Goodwin, 1968, Leprosy review.

Notes: Revised Nomenclature of Campylobacter pyloridis

B. Marshall, C. Goodwin, 1987 .

Revised Nomenclature of Campylobacter pyloridis

B. Marshall, C. Goodwin, 1987 .

Restriction endonuclease analysis of the genome of Campylobacter pylori with a rapid extraction method: evidence for considerable genomic variation.

C. Goodwin, S. Majewski, Suzanne I. H. Majewski, 1988, The Journal of infectious diseases.

Enterotoxigenic Aeromonas hydrophila and diarrhoea in adults

C. Goodwin, V. Burke, M. Gracey, 1983, The Medical journal of Australia.

Influence of soluble haemagglutinins on adherence of Helicobacter pylori to HEp-2 cells.

J. Armstrong, C. Goodwin, M. Cooper, 1991, Journal of medical microbiology.

Microbiology of Helicobacter pylori.

C. Goodwin, B. Worsley, 1993, Gastroenterology clinics of North America.

The use of flufenamic acid in acute complications of leprosy, and the associated lowering of raised serum transaminase levels.

C. Goodwin, M. Wood, 1970, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

Urinary and plasma organic acids and amino acids in chronic fatigue syndrome.

J. Barron, C. Goodwin, R. Chalmers, 2005, Clinica chimica acta; international journal of clinical chemistry.

Plasma and urinary carnitine and acylcarnitines in chronic fatigue syndrome.

C. Goodwin, R. Chalmers, Saira Amjad, 2005, Clinica chimica acta; international journal of clinical chemistry.

CFSUM1 and CFSUM2 in urine from patients with chronic fatigue syndrome are methodological artefacts.

C. Goodwin, R. Chalmers, Saira Amjad, 2006, Clinica chimica acta; international journal of clinical chemistry.

Bacteria isolated from plantar ulcers of Ethiopian leprosy patients, with the antibacterial drug sensitivities of the isolates.

C. Goodwin, M. Wood, 1970, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Helicobacter nemestrinae sp. nov., a spiral bacterium found in the stomach of a pigtailed macaque (Macaca nemestrina)

C. Goodwin, L. Sly, F. Schoenknecht, 1991, International journal of systematic bacteriology.

The absence of thermoplasmaquinones in Campylobacter pyloridis, and its temperature and pH growth range

M. Collins, C. Goodwin, E. Blincow, 1986 .

Helicobacter pylori: 10th anniversary of its culture in April 1982.

C. Goodwin, 1993, Gut.

Hydrophobic characterisation of Helicobacter (Campylobacter) pylori.

P. McDonald, C. Goodwin, H. Pruul, 1990, Journal of medical microbiology.

O ANTIGEN LOSS BY SEMI‐ROUGH E. COLI CAUSING RECURRENT URINARY INFECTIONS, ANALYSED BY GEL COLUMN FILTRATION AND GAS‐LIQUID CHROMATOGRAPHY

C. Goodwin, J. Green, L. Webb, 1982, Pathology.

Loss of urease activity in Helicobacter mustelae

C. Goodwin, D. Morgan, R. Owen, 1991 .

Two urease activities with different pH optima in Campylobacter pylori and similar organisms

C. Goodwin, Mark B. Taylor, Q. Karim, 1988 .

Differences Between in Vitro and in Vivo Sensitivity of Campylobacter pylori to Antibacterials

J. Armstrong, C. Goodwin, D. Wilson, 1988 .

Dormancy and Low-Growth States in Microbial Disease: Gastritis and peptic ulceration

C. Goodwin, 2003 .

Haemagglutinins of Helicobacter pylori and Adherence to HEp-2 Cells

C. Goodwin, 1994 .

Campylobacter pyloridis in patients with gastric carcinoma

C. Goodwin, C. Sanderson, S. Cheng, 1987, The Medical journal of Australia.

Breath Tests To Detect Helicobacter Pylori

C. Goodwin, 2018 .

Gastric cancer and Helicobacter pylori: the whispering killer?

C. Goodwin, 1993, The Lancet.

An outbreak of common colds at an Antarctic base after seventeen weeks of complete isolation

C. Goodwin, A. Bradburne, D. Tyrrell, 1973, Epidemiology and Infection.

Beta-Lactamase Resistance of Cephazolin and other Cephalosporins

C. Goodwin, J. Hill, 1975 .

Interaction of Campylobacter pyloridis with human immune defence mechanisms.

P. Lee, P. McDonald, C. Goodwin, 1987, Journal of medical microbiology.